Q1 FY 2026 results

Rossari Biotech Limited, one of India’s leading specialty chemicals manufacturer has presented it Q1 FY 2026 numbers today. Here are details –

The Company has posted revenue from operations of INR 543.72 Cr for the quarter ended 30 June 2025 as against revenue of INR 489.65 Cr same period last year, registering a growth of 11 percent Y-o-Y basis. However, on Q-o-Q basis the revenue declined by 6 percent (INR 579.5 Cr).

Total expenses of the company increased by 12 percent Y-o-Y basis (INR 499 Cr for 30 June 2025 v/s 444 Cr for 30 June 2024)

Rossari has registered Profit After Tax (PAT) of INR 33.60 Cr for the quarter ended 30 June 2025 as against Profit of INR 35 Cr for the period ended 30 June 2024, a de-growth of 4 percent Y-o-Y basis.

Managing Director Speech –

Commenting on the performance, Mr. Edward Menezes, Promoter & Executive Chairman, and Mr. Sunil Chari, Promoter & Managing Director, said –

We delivered a steady performance in Q1 FY26, with topline growth driven by strong momentum in our HPPC and AHN segments. Despite a challenging and evolving operating environment, our core businesses continued to demonstrate resilience. Though our export business was lower compared to the last quarter, it has shown healthy growth over the last year. While overall growth remained healthy, we are confident that our continued efficiency initiatives and focused efforts on optimizing the product mix will continue to drive growth over the coming quarters.

Looking ahead, we remain committed to execution excellence, customer-led innovation, and sustainable value creation. Supported by a robust balance sheet, a strong R&D foundation, and our ongoing capacity expansion initiatives, we are well-positioned to navigate near-term challenges and deliver consistent, profitable growth for all stakeholders.

Daily Chart –

The stock ended at INR 743 on Friday (July 18, 2025) and is trading 24% below its 52-week high of INR 973 on the National Stock Exchange.

Rossari is trading well above its 20 DEMA (695) and 200 DEMA (729) when looking at the daily chart.

LAST ARTICLE – Sterling and Wilson Renewable Energy

23 July 2020

Update:

Rossari Biotech Listing:

Rossari Biotech Limited – one of India’s prominent specialty chemical manufacturing companies started its very first first trading day with a whopping 57.65% premium over its IPO price today.

On the National Stock Exchange, the share price traded at INR 676.75, up by INR 251.75 or 59.24% over IPO price, with volumes of 40,88,564 equity shares.

On the NSE, the stock made a high of INR 803.10 and a low of INR 664 before it ended at INR 741.65 on the National Stock Exchange, up 74.51% when the market closed.

In terms of volumes, Rossari Biotech Limited traded with 35,781,623 shares on the NSE.

Read: Finblab Valuepick Stock Escorts Limited

9 July 2020

Rossari Biotech Limited is amongst India’s leading textile and specialty chemical manufacturers – is planning to raise INR 496.25 Cr via IPO [50 Cr Fresh Issue + 446.25 Cr OFS]

Rossari Biotech: Company Profile

Rossari Biotech was founded in the year 2003 as a partnership firm in the name of Rossari Labtech by Edward Walter Menezes and Sunil Srinivasan Chari, who are both career-technocrats cumulatively having more than 45 years of experience in the specialty chemicals industry.

It was further renamed to Rossari Biotech Limited and converted into a company in the year 2009.

Rossari Biotech: Business

Rossari Biotech Ltd is one of India’s prominent specialty chemical manufacturing companies and provides customized solutions to specific industrial and production requirements of its customers.

The business of the company can be classified into 3 main categories –

• home, personal care, and performance chemicals;
• textile specialty chemicals; and
• animal health and nutrition products

As per the F&S Report published on 30th Sept 2019, it is the largest textile specialty chemical manufacturer in India.

As of 31 January 2020, Rossari Biotech Limited had a range of 1,960 different products across 3 categories.

Rossari Biotech: Manufacturing Facilities

Most of the products of the company are manufactured in-house.

The Company has a manufacturing unit located at Silvassa, Dadra & Nagar Haveli with an installed capacity of 100,000 MTPA.

The company is also setting up a manufacturing unit at Dahej (Gujarat) will be commissioned in fiscal 2021 with an installed capacity of 132,500 MTPA.

Rossari Biotech: R&D facilities

Rossari Biotech also has 2 R&D facilities, one in Silvassa and second in Mumbai to focus on new product development, formulations, and cost competitiveness.

Company Strength:

The Company has more than 194 distributors across India and 27 distributors spread in other 17 countries.

Rossari: Competitive Strengths

• Diversified product portfolio addressing the needs of varied customers
• Largest textile specialty chemical manufacturer in India
• Extensive manufacturing and technical capabilities
• Solid R&D skills with a focus on innovation and sustainability
• Wide sales and distribution network
• Experienced Promoters with a strong management team

Company Promoters:

Mr. Edward Menezes is the Executive Chairman and Co-Founder of the Company and mentors the Company’s technical, manufacturing, and marketing initiatives. He comes with a vast breadth of experience spread over 34 years of having worked in textile processing in mills.

Mr. Sunil Chari is the MD and Co-Founder who drives the growth of Rossari Biotech. His passion for the (1) business, (2) people, and (3) processes provides Rossari Biotech a competitive advantage in the market. With over 30 years of experience in textiles and ancillary chemicals, Mr. Chari brings to the table his vast knowledge and market wisdom.

IPO Opening / Closing Date

IPO Details – Price, Minimum Bid and Other

Financial Performance

CONCLUSION

Considering company’s valuation, financial parameters, and the sector potential, FinBlab recommends SUBSCRIBE ratings on Rossari Biotech Limited IPO

Must Read

Value Pick Stock of the Month: Coromandel International Limited

Disclaimer: The contents and data presented here are just for your information & personal use only. While much effort is made to provide the information, I ( Vishal Dalwadi ) or “FinBlab” do not guarantee the accuracy, correctness, completeness or reliability of any information or data displayed herein and shall not be held responsible.

The post Rossari Biotech Limited IPO – Review, Update appeared first on Upcoming ipos: Latest news on stocks, economy & finance.

“Q2 FY 2022-23 Numbers”

Clean Science and Technology Ltd – one of the leading chemical manufacturers globally has presented its Q2 FY22-23 numbers today –

On a consolidated basis the Revenue from the operations of the company stood at INR 247.51 Cr for the period ended 30 September 2022, UP 5.77% Q-O-Q basis (INR 234 Cr as on 30 June 2022) and UP 61.77% Y-O-Y basis (INR 153.16 Cr as on 30 September 2021)

For the quarter ended 30 September 2022 the Expenses of the company stood at INR 158 Cr v/s INR 151 Cr for the previous quarter.

The Company has generated PAT of INR 67.95 Cr for the period ended 30 September 2022 as compared to INR 62.90 for the previous quarter (UP 8% Q-O-Q basis) and INR 53.53 Cr a period one year ago (UP 27% Y-O-Y basis)

EPS of the company stood at INR 6.40 v/s 5.92

Clean Science – Daily Chart

Also Read: Krishna Institute of Medical Sciences – Value Pick Stock OCTOBER 2022

Disclaimer: The contents and data presented here are just for your information & personal use only. While much effort is made to provide the information, I (Vishal Dalwadi) or “FinBlab” do not guarantee the accuracy, correctness, completeness or reliability of any information or data displayed herein and shall not be held responsible.

8 August 2022

Clean Science & Technology Limited is a fine chemical and specialty chemical manufacturing company, with innovative chemical processes developed in-house.

Clean Science and Technology: History

Clean Science and Technology was established in the year 2003 as a family-owned business, and over 15 years of incorporation, the company has grown to become the largest manufacturer of certain chemicals globally.

The Company got listed (both on the NSE and BSE) on July 19, 2021, where the IPO size of the company was INR 1546 Cr of which the entire issue was an OFS (Offer for sale).

Must Read: Nifty prediction for August 2022

Clean Science and Technology: Business & Products

The Company is in the business of manufacturing critical specialty chemicals such as –

PERFORMANCE CHEMICALS which has 4 key products, namely

• MEHQ (Monomethyl ether of hydroquinone)
• BHA (Butylated Hydroxy Anisole)
• TBHQ (Tertiary Butyl Hydroquinone)
• AP (L-Ascorbyl Palmitate)

This segment contributes 70% to the company’s total revenue

PHARMACEUTICAL & AGRO INTERMEDIATES which has 3 key products, namely

• Guaiacol
• PBQ (Para Benzoquinone)
• DCC (Dicyclohexyl Carbodiimide)

This segment contributes 17% to the company’s total revenue

FMCG CHEMICALS which 2 key products, namely

• 4-MAP (4-Methoxy Acetophenone)
• Anisole

This segment contributes 13% to the company’s total revenue

Read more about the clean science and technology products list

Leading Manufacturer of Green Chemistry

Green chemistry is an evolving focus among manufacturing businesses that minimizes pollution at a molecular level.

Clean Science and Technology works on developing sustainable and eco-friendly manufacturing processes of fine and specialty chemicals and is one of the global leaders in its key products including (1) monomethyl ether of hydroquinone, (2) butylated hydroxyanisole, (3) anisole, and (4) MAP, besides in other key products including DDC and guaiacol.

Manufacturing Plants

The Company has three manufacturing facilities in Kurkumbh, MIDC (Maharashtra, India) that are automated to maintain high levels of accuracy and efficiency (each unit has a separate R&D facility, warehouse, engineering, and utility section)

Clean Science: Global Presence

Clean Science and Technology has clients from China, Europe, Japan, Korea, Taiwan, and the USA which makes it a truly global organization.

The company also supplies its products to manufacturers and distributors in India and Bayer AG, Genex Laboratories Limited, Nutriad International NV, SRF Limited, and Vinati Organics are some of its few valuable clients.

Listed On:

The share of Clean Science & Technology Ltd is presently listed on the Bombay Stock Exchange (BSE); CODE 543318 and National Stock Exchange (NSE) as CLEAN

Stock Info: Clean Science & Technology

Share Holding Pattern

Financials

Conclusion

Clean Science and Technology Ltd is one of the prominent chemical manufacturers worldwide.

Promoters of the company are having more than 78% stake with 0% pledge shares.

Along with this, some of the top institutions like Nomura India Investment Fund Mother Fund, Axis Mutual Fund Trustee Limited, and Anantroop Financial Advisory Services Private Limited is having more than a 1% stake in the company (as of June 2022).

Clean Science consolidated numbers for June 2022 are Net Sales at INR 234 Cr (UP 60% Y-O-Y and 14.4% Q-O-Q) while Net Profit at INR 62.90 Cr in June 2022 (UP 15.18% Y-O-Y and 0.8% Q-O-Q)

In FY22, the company incurred INR 140 Cr of capacity expansion towards all three units (all capacity expansion was funded through internal accruals) which help clean science going forward.

On the technical front, the clean science and technology share is trading near its 20 EMA (1645) and 50 EMA (1656) on the daily chart.

Keeping the above-listed factors in mind, Clean Science looks good at INR 1625. Finblab recommends investing in the stock in a staggered manner for the medium to the long haul (3 to 5 years period).

Disc: Finblab (vishal dalwadi) is holding Clean Science in his long-term portfolio.

—————————————————————————————————————————————–

Disclaimer: The contents and data presented here are just for your information & personal use only. While much effort is made to provide the information, I (Vishal Dalwadi) or “FinBlab” do not guarantee the accuracy, correctness, completeness or reliability of any information or data displayed herein and shall not be held responsible.

—————————————————————————————————————————————–

The post Clean Science & Technology Limited: Value Pick Stock August 2022, Update appeared first on Upcoming ipos: Latest news on stocks, economy & finance.